Earnings Summary

Medtronic Plc’s revenue jumped 0.53% since last year same period to $8589Mn in the Q2 2024. On a quarterly growth basis, Medtronic Plc has generated 6.18% jump in its revenue since last 3-months.

Medtronic Plc’s net profit fell -44.53% since last year same period to $654Mn in the Q2 2024. On a quarterly growth basis, Medtronic Plc has generated -50.53% fall in its net profits since last 3-months.

Medtronic Plc’s net profit margin fell -44.82% since last year same period to 7.61% in the Q2 2024. On a quarterly growth basis, Medtronic Plc has generated -53.41% fall in its net profit margins since last 3-months.

Medtronic Plc’s price-to-earnings ratio after this Q2 2024 earnings stands at 28.97.

Medtronic Plc’s earning per share (EPS) estimates for the current quarter stand at 1.2 - a -17.24% fall from last quarter’s estimates.

Medtronic Plc’s earning per share (EPS) estimates for the current year stand at 1.2.

Medtronic Plc’s earning per share (EPS) fell -7.01% since last year same period to 1.46 in the Q2 2024. This indicates that the Medtronic Plc has generated -7.01% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Medtronic Plc’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Medtronic Plc’s return on equity (ROE) stands at 0.07.

Medtronic Plc declared 0.7 dividend per share during the earnings announcement for Q2 2024.